# Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study

> **NCT02514499** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 350 (—)

## Conditions studied

- BRCA1/2 Negative

## Interventions

- **OTHER:** Questionnaires

## Key facts

- **NCT ID:** NCT02514499
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2018-10
- **Final completion:** 2018-10
- **Target enrollment:** 350 (—)
- **Last updated:** 2019-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02514499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02514499, "Multiplex Testing for Evaluation of Breast Cancer Risk, Longitudinal Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02514499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*